Cipro Articles
USA’s FTC files amicus brief in support of rehearing of ciprofloxacin "pay-for-delay" case
27 May 2010
UAE patients pay four-fold more for drugs, claims HAI
26 January 2010
Aradigm drug reduces pulmonary bacteria
26 January 2009
Novartis to acquire Nektar unit for $115M
27 October 2008
Court of Appeal upholds 2005 Barr/Cipro decision
27 October 2008
Expert updates on current CF pipeline
13 October 2008
Black box warnings on fluoroquinolone
14 July 2008
Pharma to be creative on generics threat
5 May 2008
US Public Citizen group sues the FDA over antibiotics warnings
14 January 2008
FDA clears new indication for Ortho-McNeil's Levaquin
24 September 2007
Depomed and Esprit end ProQuin XR deal
16 July 2007
COMP adopts positive opinion on 10 new drugs
9 July 2007
NHI price cuts hit Bayer Yakuhin results
23 April 2007
Beximco starts selling generics to Ghana
9 April 2007
Bayer donates $25M worth of antibiotics to MAP
22 December 2006
Schering AG buy boosts Bayer but charges take toll on profit; 3rd-qtr beats forecasts
4 December 2006
Indian Pharma cuts 886 drug prices
13 November 2006
Japan stock market week to Aug 28, 2006
4 September 2006
FDA petitioned for warnings on fluoroquinolones
4 September 2006
FDA approves generic version of Bayer's Cipro
4 September 2006
Bayer Yakuhin sees 2005 sales rise 4%
1 May 2006
Japan to discuss pediatric drug use
10 April 2006
Sweden's drug authority starts ProQuin review
3 April 2006
Depomed/Madaus in European ProQuin XR distribution deal
5 December 2005
Depomed and Esprit ink Proquin license deal
8 August 2005
Avanir's anthrax Ab shows promise in trial
13 June 2005
Depomed's Proquin gets FDA OK
30 May 2005
Better outlook for Bayer HealthCare
16 May 2005
Akorn debuts two ophthalmic drug products
9 May 2005
UPDATE: Bayer sees 1st-qtr profits leap 50%
9 May 2005
Bayer 1st-qtr profits up 50%
9 May 2005
India's Supreme Court OKs NNPA price orders
18 April 2005
Barr prevails in Bayer Cipro patent dispute
11 April 2005
Bayer and Nektar collaborate on novel Cipro
31 January 2005
FDA approves Hi-Tech's ciprofloxacin ophthalmic solution
31 January 2005
Brand-name pharma striking "authorized generics" deals
13 December 2004
Barr's 1st-qtr profit up despite sales decline
15 November 2004
Rapid uUTI symptom improvement with Bayer's Cipro XR
25 October 2004
Spectrum gains first ANDA approval, for ciprofloxacin
20 September 2004
Bayer and Schering-Plough form strategic pharmaceuticals alliance
20 September 2004
Bayer sees shares dip on mixed 2nd-qtr
6 September 2004
Editor's views on Sanofi-Aventis
16 August 2004
Indian results show generics losing shine
16 August 2004
Barr posts record revenues for fiscal 2004
16 August 2004
Depomed files NDA for Proquin XR
26 July 2004
Four drugmakers gain US appro for generic Cipro
14 June 2004
Dr Reddy's sees full-year sales climb 11%
7 June 2004
Bayer continues to focus on anti-infectives
10 May 2004
Drug price, shortages foreseen in India
3 May 2004
Positive new data for Ciprofloxacin G
29 March 2004
Barr 2nd-qtr turnover rockets 79%
16 February 2004
Stock Commentary - Europe
5 January 2004
Bayer's Cipro gets extra exclusivity in USA
5 January 2004
Ranbaxy to launch new products in China
29 September 2003
India's NPPA seeks to recover millions of rupees from 50 local companies
15 September 2003
Bayer's profits tumble in second quarter
11 August 2003
FDA clears Alcon's Ciprodex Otic
28 July 2003
Ranbaxy revises target on US sales
14 July 2003
Stock Commentary - New York
23 June 2003
Barr begins shipping ciprofloxacin
16 June 2003
Spectrum files for Cipro generic in USA
19 May 2003
Profits up at Bayer on acquisition benefits
12 May 2003
Pliva closes deal to acquire Spain's Edigen
7 April 2003
Pliva to buy generics firm in Spain
17 February 2003
Stock Commentary - Europe
19 August 2002
Rise in US lawsuits for generic blocking
22 April 2002
WHO recommends AIDS drugs, makers
1 April 2002
Bayer files once-daily ciprofloxacin in USA
18 March 2002
Bayer realigns US pharma sales force
11 February 2002
In new job, Canadian Minister backs patents
28 January 2002
US AGs file to stop on-line Cipro sales.
21 January 2002
Indian drugmakers Dr Reddy's and Ranbaxy expand sales.
21 January 2002
Teva gets tentative OK for generic Cipro
7 January 2002
Pharma industry views WTO's "political" Doha Declaration on TRIPs
21 November 2001
Indian firms view ciprofloxacin moves
20 November 2001
Bayer reports heavy loss as impact of Baycol withdrawal takes hold
15 November 2001
US bill to ease urgent generic Rx production
12 November 2001
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
